based in california Biolinq, a health technology company developing highly accurate, multi-analyte wearable biosensors for metabolic health, announced that it has secured $58 million in funding.
Alpha Wave Ventures led the round, with participation from Niterra's corporate venture capital fund co-managed with Pegasus Tech Ventures.
Existing investors including AXA IM Alts, Senvest Management, Feature Capital, Aphelion Capital, RiverVest Venture Partners, and Taisho Pharmaceutical also participated in the financing.
Biolinq has created a wearable patch that assesses blood sugar levels and activity levels. This patch uses small electrochemical sensors to measure glucose levels from the intradermal space below the surface of a person's skin.
The company plans to use the funds to conduct clinical trials and submit its glucose sensor to the FDA.
“Our technology approach allows biosensing to access coveted metabolically active compartments of the skin without introducing needles or bleeding,” Biolinq CEO Rich Yang said in a statement. It will be possible to do so.” “For the past 10 years, our team has been on a mission to inform, inspire and reach more people in need of simple solutions to improve their metabolic health. We have pioneered a new biosensor platform designed to
EarliTech Diagnostics, a company developing diagnostic and treatment services for children with autism, has secured $21.5 million in Series B funding led by Nexus NeuroTech Ventures and Venture Investors Health Fund.
The Georgia-based company offers EarliPoint Evaluation, a platform that helps clinicians diagnose and evaluate children with autism between the ages of 16 and 30 months.
Children watch social interaction videos on tablets. At the same time, biomarkers track children's concentration, proxy for clinicians' diagnoses, and assess functional levels of traits such as language ability and nonverbal learning.
The company plans to use the funding to advance its technology, further commercialize its products and advance clinical research.
Manifold, an AI-enabled clinical research platform, announced its launch with $15 million in Series A funding led by TQ Ventures.
New investors SK Ventures and Calibrate Ventures participated in the round along with Dr. Sachin H. Jain and existing investor TTCER Partners.
The company provides an AI-powered platform for clinical research aimed at streamlining workflow and data management. It enables researchers to manage cohort studies and patient registries, manage observational study workflows, and provide a patient portal with surveys, consent tracking, and digital outreach.
Built from employee benefits platform Beanstalk Benefits Redesign Health announces launch with $7.5 million in funding.
The company provides employees with a platform where they can choose their daily benefits, including health, welfare and benefits services, rather than having their employer choose for them.
Benefits include services such as chronic disease management, child care, personal finance, elder care, fertility, and mental health services. Employers, rather than individual companies, contract with Beanstalk to provide a variety of benefits.
“We've spent the last year investing in the platform itself. Employees have never previously chosen non-insurance benefits for themselves and aren't necessarily familiar with what's out there, so it's an intuitive approach. It was important to us to create a unique user experience. We believe that they can leverage all the benefits innovations out there to adapt their portfolio to meet their unique needs. They'll be very excited to discover how much they can customize their products,” said Matthew Sidney, CEO and co-founder of Beanstalk Benefits. Mobi Health News on mail.
“Next steps, now that the platform is available in a broader market, will focus on strengthening employer onboarding and customer service teams. With Beanstalk up and running within days of turn-on, “We're investing in even more enhancements to how easy Beanstalk is to work with. We're also investing in how easy it is to work with Beanstalk. We continue to refine and add new benefits solutions to our suite, with the aim of creating the most comprehensive resource possible.”
